Verve Therapeutics

$33.51 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Verve Therapeutics

Verve Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops therapies that safely edit adult human genome to permanently reduce a person's risk of coronary artery disease. Verve Therapeutics serves customers worldwide.

Stock Analysis

last close $30.73
1-mo return -21.7%
3-mo return -29.2%
avg daily vol. 461T
52-week high 78
52-week low 29.5
market cap. $1.6B
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 58.1%

Subscribe now for daily local and international financial news